- Home
- News
- canada saskatchewan
- laparoscope
Refine by
Laparoscope Articles & Analysis
60 news found
ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced the winners of its 2017 weight loss contest, which recognizes patients for their successful weight loss with the ReShape Balloon™. The contest winner lost a total of 80 pounds, or 41% total weight loss (TWL), with 60 pounds, or 28% TWL, lost ...
New Calibration Tubes, in Three Sizes, Will Simplify Gastric and Bariatric Procedures Including Laparoscopic Sleeve Gastrectomy, Gastric Bypass and Gastric Banding Company to Introduce Product at IFSO 2022 World Congress in August; Sales to Commence in September ReShape Lifesciences (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced ...
ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Board of Directors has appointed Paul F. Hickey as President and Chief Executive Officer and as a member of the Board of Directors, effective August 15, 2022. Mr. Hickey succeeds Bart Bandy, who has separated from the company to pursue other ...
On-demand robotics is a new technique for laparoscopic surgery. It has been used in Germany for the first time by the Department for Women’s Health and Gynecology at the University Hospital Tübingen. Together with the University Hospital Tübingen we announced today the successful completion of gynecological surgeries using Dexter®. This marks Dexter’s first clinical ...
Saintonge Hospital is the first institution worldwide to introduce on-demand robotics with Dexter® in routine daily use. Dr. Damien Emeriau and Dr. Guillaume Hugues from the urology department of Saintonge Hospital welcomed the Sud-Ouest newspaper into their OR, to explain how on-demand robotics with Dexter has changed their daily practice. Dr. Emeriau comments on the superior precision ...
Surgeons at Lausanne University Hospital (CHUV) perform the world’s first hybrid robotic general surgery. Distalmotion and CHUV announce the launch of a clinical study. The CHUV’s Division for Visceral Surgery is at the forefront of establishing a new standard of patient care, and will become a global reference center for hybrid robotic surgery with Dexter. Distalmotion and ...
Sensor advancements are driving innovation in both wearable devices and surgical devices. Speakers at the MD&M West 2020 conference explore several developments. The role of sensors in medical devices is becoming increasingly more important, especially when it comes to developing new technologies such as wearable devices that can diagnose and transmit information for long periods of ...
Rani Therapeutics Holdings, Inc. recently announced the development of a high-capacity oral biologics device known as the RaniPill HC (High Capacity), capable of delivering up to a 500%-plus higher drug payload than Rani’s existing oral biologics capsule. In preclinical testing, RaniPill HC demonstrated successful delivery of adalimumab and achieved high bioavailability. “The ...
PISA, Italy. June 8.2022 - Medical Microinstruments (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in "THE MINIMALLY INVASIVE ROBOTIC SURGERY SYSTEMS project (TREMIRS). REFERENCE: CPI-2019-33-1-TRE-14. in the framework of the Line for the Promotion of Innovation from the Demand for the Public ...
BOSTON — May 24, 2022 — Activ Surgical™, a digital surgery pioneer, today announced the successful completion of an Institutional Review Board (IRB) study using its ActivSight™ intraoperative imaging module at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB) in New York. The 40-patient study was led by principal investigator Dr. ...
TORONTO--(BUSINESS WIRE)-- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three months ended March 31, 2022. “The entire team is focused on driving performance and progress supporting our IDE ...
NMPA clearance expands global Phase 3 clinical development program; Company recently announced clearance from U.S. Food and Drug Administration to commence Phase 3 study Newsoara to fully fund Phase 3 program in China Under the Co-Development Agreement, commencement of Phase 3 program in China will trigger milestone payment to Palisade Bio Palisade Bio (Nasdaq: PALI), a clinical stage ...
Saintonge Hospital is the first healthcare institution in France to purchase and install the novel Dexter® surgical system. Dexter’s clinical versatility will provide on-demand robotic aid to help improve patient outcomes in general surgery, gynecology and urology. Saintonge Hospital has purchased and installed its first surgical robot: Distalmotion’s Dexter®. This marks ...
Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, announced today the sale of its in-office MRI system to Beverly Hills Urology. Promaxo’s single-sided MRI with AI based imaging system, FDA cleared for in-office use, empowers practices and hospitals to accurately and seamlessly guide prostate interventions under the ...
CMR Surgical & Surgical Innovations develop new surgical hybrid port access system Surgical Innovations’ new YelloPort Elite™ 5mm, with reusable trocar and canula, reduces cost and waste generated when compared with traditional fully single use Port Access Systems Developed with CMR Surgical, the port access system is the latest addition to Surgical Innovation’s ...
Data from Pooled-Analysis of Enteral Protease Inhibitor LB1148 Demonstrated 72% Reduction in the Risk of Adhesion Formation in Patients Undergoing Bowel Resection Surgery Company to Host Conference Call on Wednesday, March 16, 2022, at 8:30 a.m. EST Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) ...
Dexter is coming to Italy. Together with NBA Medica we plan to make robotics more accessible, user-friendly and versatile for Italian surgeons in the fields of general surgery, gynecology and urology. Left to right: Cristiano Fontana, Head of Business Development at NBA Medica and Marco Sesenna, CEO NBA Medica, in Lausanne at Distalmotion HQ with Dexter. ©Distalmotion Distalmotion has ...
Rani Therapeutics has developed an oral biologics device, named RaniPill HC, for the delivery of biologics. The new device is capable of delivering a drug payload of up to or more than 500% higher compared to the company’s current oral biologics capsule. A preclinical study of RaniPill HC has been conducted by the company, in which the device was administered to subjects with an 18mg dose ...
Distalmotion, Revival Healthcare Capital and 415 CAPITAL announce the closing of a USD 90 million Series E financing round to accelerate the adoption of Distalmotion’s surgical robot Dexter. The investment follows Dexter’s successful initial clinical use and supports Distalmotion’s international commercial scaling. More than capital: A partnership of medtech pioneers and ...
Theramx announced on the 14th that it has signed an annual export contract with the Madrid Regional Health Agency, Spain, and has completed the delivery of the product. The product exported to Spain is EG-Q Bond, a bioadhesive for epidermal bonding that joins the affected area without using a separate suture for 20,000 endoscopic and laparoscopic surgeries. A Theramx official said, ...